Correction: Prediction of personalized antiseizure medications response based on clinical signatures in epilepsy

Scientific Reports 2026 Open access

Read full text
Authors: Kyung-Il Park, Youmin Shin, Sungeun Hwang, Yong-Jeong Kim, Yong-Jeong Kim, Seung-Bo Lee, Seung-Bo Lee, Hyoshin Son, Jangsup Moon, Soon-Tae Lee, Soon-Tae Lee, Keun‐Hwa Jung
+6 more Kon Chu, Ki‐Young Jung, Young-Gon Kim, Young-Gon Kim, Sang Kun Lee, Sang Kun Lee
DOI: 10.1038/s41598-026-37481-3
Cited by: 0

Abstract

Additionally, “The AUCs of common dual regimens were 0.543 for levetiracetam + oxcarbazepine, 0.454 for levetiracetam + valproate, and 0.583 for levetiracetam + lamotrigine. Levetiracetam + carbamazepine showed the highest AUC, 0.686.”

Fields of Study & Subjects

Epilepsy research and treatment Machine Learning in Healthcare Pharmacological Effects and Toxicity Studies

Publication details

Journal / source
Scientific Reports
Volume
16
Issue
1
Pages
4524–4524
Publication date
2 February 2026
Language
EN